Whether it be acute or chronic, almost every single one of us will experience a respiratory illness at some point in our lives, and thanks to smartphone app ResApp, the common cough Is being used to help diagnose and manage that illness. And it’s not just asthma, pneumonia, COPD and COVID the company is tackling with intuitive algorithms analysing cough sounds, with a secondary platform also released that’s able to indicate the presence of sleep apnoea. Meet Dr Rukhsana Rehman, a passionate telehealth practitioner using ResApp to improve the accuracy of respiratory disease diagnosis, and meet medical student Victoria, an asthma sufferer who says apps like ResApp could greatly improve the lives of asthma sufferers everywhere.

The name behind the innovation

Tony Keating – Chief Executive Officer and Managing Director

www.resapphealth.com.au

See omnystudio.com/listener for privacy information.

When it comes to preventing sexually transmitted infections there are limited options. And the options we do have - condoms - lack desirability, so much so that most of us avoid using them. Revolutionising the condom for the first time in over 100 years is Eudaemon Technologies. Their tech, Gel-dom, is turning a  ‘need to’ into a ‘want to’ which could have a major impact on the rates of STIs and unintended pregnancies. Greg Fisher, CEO of Qtopia, discusses the role of condoms in the fight against HIV/AIDS, and the mental and societal toll of STI stigma. And we meet Professor Deb Barton, a sexual health expert who deep dives into the importance of sexual health literacy and why choice in contraceptives is vital to ensure people stay safe and satisfied.

See omnystudio.com/listener for privacy information.

When the nerves are damaged, recovery is slow and painful; and even with nerve transfer surgery, there’s no guarantee that movement and feeling will be restored. Regenerative medicine company, Orthocell, are making the impossible possible, restoring movement and feeling for patients through a resorbable collagen scaffold that encourages the reformation of new nerve tissue. Damien, a downhill skateboard rider, recounts the accident that rendered his arm immobile, and how he rediscovered his purpose following his treatment with the Orthocell product, Remplir. We chat to Paul Anderson, the brain driving the innovation, and Dr Alex O’Bierne, the Orthopaedic Surgeon who pioneered Orthocell’s operative technique.

The name behind the innovation

Paul Anderson – CEO and Managing Director of Orthocell

orthocell.com

Dr Alex O’Beirne  - Orthopaedic Surgeon Fiona Stanley Hospital and Western Orthopaedic Clinic
 www.wocwa.com.au/surgeons/alex-obeirne/ 

See omnystudio.com/listener for privacy information.

Everyday, thousands of Australians go without basic medical care as a result of where they live or work. Those who live remote, or considered to be ‘medically isolated,’ face daily environmental, financial, and circumstantial barriers to accessing healthcare. Visionflex are closing this gap, with an innovative telehealth solution that promotes widespread medical care for all. Hear from David and Marianne about their work delivering digital health clinics into remote indigenous communities, and Shirley, whose experience across two decades of aged care has made her an advocate for equitable access. We also meet Rod and Carol, who share insights into how they’ve integrated Visionflex in their service to preserve the autonomy of the elderly.  

The name behind the innovation

Mike Harman – CEO and Founder of Visionflex

www.visionflex.com

See omnystudio.com/listener for privacy information.

Central venous catheters, or central lines, deliver life-saving medication to critically ill neonatal and paediatric patients, yet 40% of them are misplaced or migrate due to a serious shortage in fit-for-purpose medical products. Pioneers in the neonatal innovation space, Navi Medical Technologies, are solving this problem with a device enhancing central line placement tailored for bodies as small as 500 grams. Hear the story of Sarah and James, whose son Archie spent 210 days in the NICU, and meet Vascular Access Nurse Stephanie Pitts, and Neonatal Fellow Gillian Foo, who discuss the importance of giving every child the best start from day one.

The names behind the innovation

Alex Newton – CEO, Executive Director, and Co-Founder of Navi Medical Technologies

Christiane Theda – Chief Medical Officer, Executive Director, and Co-Founder of Navi Medical Technologies

navitechnologies.com

See omnystudio.com/listener for privacy information.

Cardiac rehabilitation programs can significantly reduce the risk of subsequent events, yet 80 percent of patients do not participate in these lifesaving programs. One of the key barriers to participation - access - is being reimagined by Cardihab, a digital health app putting cardiac rehabilitation in your back pocket. In this episode we meet Paul, a father of two who struggled to adhere to cardiac rehabilitation until his second cardiac event, and cardiac rehabilitation nurse, John, who explains how clinicians are using the platform to deliver better treatment plans and brighter outcomes for patients living with heart disease.

The name behind the innovation

Helen Souris – CEO of Cardihab

https://cardihab.com/

See omnystudio.com/listener for privacy information.

In the operating room, the removal of cancerous breast tissue is largely determined by what the surgeon can or cannot feel. This can often result in repeat surgeries for many patients; when cells that went unnoticed at first are subsequently discovered following treatment. OncoRes Medical is giving confidence back to surgeons and patients with a device that can detect and visualise cancer on a microscale, reducing the need for painful and often disheartening repeat surgeries at one of the most challenging times of a person's life. In this episode, Ash shares her experience navigating a cancer diagnosis that saw her need several operations, and we meet the people behind this game changing device.

The names behind the innovation

Dr Katharine Giles - CEO and Managing Director of OncoRes Medical Professor Christobel Saunders - Chief Medical Officer at OncoRes Medical www.oncoresmedical.com

See omnystudio.com/listener for privacy information.

Research tells us that as many as one in four adults, and two in three children, experience strong fear and anxiety when anticipating a needle. Smileyscope is hoping to address those fears, with a device that immerses its consumers in a virtual reality journey, where that needle is simply part of the story.  Be it a dive underwater with fish, coral, and penguins, or a magical garden full of butterflies, the Smileyscope is creating an experience that is leaving many previously anxious patients excited about their next appointment! Vanessa shares how her daughters, Addy and Holly, have been helped by this innovation, and we meet Brendan, an adult who faints at the sight of needles.

The name behind the innovation

Dr Evelyn Chan, CEO of Smileyscope

smileyscope.com.au 

See omnystudio.com/listener for privacy information.

As the understanding grows that mental health conditions such as depression or anxiety can affect anyone, so does the use of associated medications such as antidepressants. Currently, as many as 1 in 5 Australian adults are now being prescribed antidepressants, however, it is not widely known that not all such medications work the same for all patients. So how do you know you are getting the medication that is best suited to you? Your genetics could be the answer. By taking a simple cheek swab and using CNS Dose technology, Associate Professor Ajeet Singh, believes that a customised approach achieves better results for patients when treating their mental health. 

The name behind the innovation

Associate Professor Ajeet Singh – Psychiatrist & Founder and Director of CNSDose

https://cnsdose.com/

See omnystudio.com/listener for privacy information.

For many chronic pain sufferers, treatment options are limited to either polypharmacy or invasive surgeries, each coming with its own unique set of side effects and risks. However, could a virtual reality headset be another option? Wilfred Lax and Dhani Sutanto believe so.  They explain why virtual reality is the future of chronic pain management, and how they envision their innovative technology, the Trancedeucer and CognitiVR, fitting into that future. We also look at the virtual reality pain management method, through the eyes of pain sufferers, Jessica and Samira.

The names behind the innovation

Wilfred Lax - Founder of Neurotechnology,

Dhani Sutanto - Co-founder and CCO of Neurotechnology

https://neurotechnology.com.au/

See omnystudio.com/listener for privacy information.